Showing 2976 results
-
Event / Sep 24, 2025At this year’s European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Annual Meeting, we will be sharing the latest data and research from our neuroscience portfolio, driven by…
-
Press release /ARTIOS Phase IIIb, open-label, single-arm, prospective study showed a substantial reduction in disease activity in people with relapsing multiple sclerosis (RMS) following switch to Kesimpta after…
-
Press release /Tourmaline Bio is a clinical-stage biopharmaceutical company developing pacibekitug, an anti-IL-6 mAb, as a treatment option for atherosclerotic cardiovascular diseasePacibekitug is a…
-
Story / -
Event / Sep 17, 2025
-
Event / Aug 28, 2025At this year’s European Society of Cardiology (ESC) Congress, we will be sharing the latest data and research from our cardiology portfolio, driven by our mission to ensure that no heart is lost too…